3beta-[(2,6-Dideoxy-3-O-methyl-4-O-beta-D-glucopyranosyl-beta-D-galactopyranosyl)oxy]-16beta-acetoxy-14-hydroxy-5beta,14beta-card-20(22)-enolide

Details

Top
Internal ID 0f3c2850-4619-4a41-a0a8-68ab82a7957f
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroid lactones > Cardenolides and derivatives > Cardenolide glycosides and derivatives
IUPAC Name [(3S,5R,8R,9S,10S,13R,14S,16S,17R)-14-hydroxy-3-[(2R,4R,5S,6R)-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] acetate
SMILES (Canonical) CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CC(C5C6=CC(=O)OC6)OC(=O)C)O)C)C)OC)OC7C(C(C(C(O7)CO)O)O)O
SMILES (Isomeric) C[C@@H]1[C@@H]([C@@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@@H]4[C@@H]3CC[C@]5([C@@]4(C[C@@H]([C@@H]5C6=CC(=O)OC6)OC(=O)C)O)C)C)OC)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O
InChI InChI=1S/C38H58O14/c1-18-34(52-35-33(44)32(43)31(42)27(16-39)51-35)25(46-5)14-29(48-18)50-22-8-10-36(3)21(13-22)6-7-24-23(36)9-11-37(4)30(20-12-28(41)47-17-20)26(49-19(2)40)15-38(24,37)45/h12,18,21-27,29-35,39,42-45H,6-11,13-17H2,1-5H3/t18-,21-,22+,23+,24-,25-,26+,27-,29+,30+,31-,32+,33-,34+,35+,36+,37-,38+/m1/s1
InChI Key ITYAEKHTQKSNBZ-YSVTVYQFSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C38H58O14
Molecular Weight 738.90 g/mol
Exact Mass 738.38265652 g/mol
Topological Polar Surface Area (TPSA) 200.00 Ų
XlogP 0.80
Atomic LogP (AlogP) 1.51
H-Bond Acceptor 14
H-Bond Donor 5
Rotatable Bonds 8

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 3beta-[(2,6-Dideoxy-3-O-methyl-4-O-beta-D-glucopyranosyl-beta-D-galactopyranosyl)oxy]-16beta-acetoxy-14-hydroxy-5beta,14beta-card-20(22)-enolide

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7964 79.64%
Caco-2 - 0.8822 88.22%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability - 0.6286 62.86%
Subcellular localzation Mitochondria 0.8047 80.47%
OATP2B1 inhibitior - 0.8733 87.33%
OATP1B1 inhibitior + 0.9066 90.66%
OATP1B3 inhibitior + 0.9615 96.15%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior + 0.7613 76.13%
P-glycoprotein inhibitior + 0.7396 73.96%
P-glycoprotein substrate + 0.7652 76.52%
CYP3A4 substrate + 0.7397 73.97%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.9026 90.26%
CYP3A4 inhibition - 0.8841 88.41%
CYP2C9 inhibition - 0.9054 90.54%
CYP2C19 inhibition - 0.9238 92.38%
CYP2D6 inhibition - 0.9467 94.67%
CYP1A2 inhibition - 0.9221 92.21%
CYP2C8 inhibition + 0.5116 51.16%
CYP inhibitory promiscuity - 0.9513 95.13%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.5527 55.27%
Eye corrosion - 0.9892 98.92%
Eye irritation - 0.9241 92.41%
Skin irritation - 0.5611 56.11%
Skin corrosion - 0.9387 93.87%
Ames mutagenesis - 0.6093 60.93%
Human Ether-a-go-go-Related Gene inhibition + 0.6584 65.84%
Micronuclear - 0.7700 77.00%
Hepatotoxicity - 0.6842 68.42%
skin sensitisation - 0.9209 92.09%
Respiratory toxicity + 0.8333 83.33%
Reproductive toxicity + 0.9000 90.00%
Mitochondrial toxicity + 0.6375 63.75%
Nephrotoxicity - 0.7965 79.65%
Acute Oral Toxicity (c) I 0.8305 83.05%
Estrogen receptor binding + 0.7752 77.52%
Androgen receptor binding + 0.8045 80.45%
Thyroid receptor binding - 0.6775 67.75%
Glucocorticoid receptor binding + 0.6639 66.39%
Aromatase binding + 0.6821 68.21%
PPAR gamma + 0.7225 72.25%
Honey bee toxicity - 0.5856 58.56%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity + 0.5100 51.00%
Fish aquatic toxicity + 0.9314 93.14%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.64% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.49% 91.11%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 96.60% 94.45%
CHEMBL1994 P08235 Mineralocorticoid receptor 96.55% 100.00%
CHEMBL1293249 Q13887 Kruppel-like factor 5 94.01% 86.33%
CHEMBL3137262 O60341 LSD1/CoREST complex 93.96% 97.09%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 91.93% 85.14%
CHEMBL5608 Q16288 NT-3 growth factor receptor 91.44% 95.89%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 88.95% 94.33%
CHEMBL5255 O00206 Toll-like receptor 4 87.69% 92.50%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 86.46% 95.89%
CHEMBL241 Q14432 Phosphodiesterase 3A 86.21% 92.94%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 85.44% 96.77%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 85.11% 94.00%
CHEMBL2581 P07339 Cathepsin D 84.31% 98.95%
CHEMBL3880 P07900 Heat shock protein HSP 90-alpha 82.57% 96.21%
CHEMBL1806 P11388 DNA topoisomerase II alpha 82.38% 89.00%
CHEMBL4208 P20618 Proteasome component C5 82.34% 90.00%
CHEMBL5028 O14672 ADAM10 81.89% 97.50%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 81.86% 97.33%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 81.35% 96.00%
CHEMBL1293277 O15118 Niemann-Pick C1 protein 80.76% 81.11%

Cross-Links

Top
PubChem 51351560
NPASS NPC43116
LOTUS LTS0213933
wikiData Q105120369